News Pfizer and Merck's diabetes contender looks to challenge Jar... Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
Views & Analysis Digital Health Round-up: Can digital resolve NHS' data secur... A round-up of this week's digital healthcare news. Marco Ricci reports.
News After missing out on CEO job, Novo's US head quits The pressure on Novo Nordisk's diabetes portfolio is mounting in the US - and the situation seems even more precarious after its top exec in the region quit.
News Novo completes major filings for blockbuster hope semaglutid... Novo Nordisk has its weekly diabetes hopeful semaglutide filed in five key markets, after submitting a dossier in Japan.
News Insulet's tubeless closed loop system shows promise Omnipod Horizon found to improve blood glucose control during the day and night.
News mySugr impresses, expands Roche partnership Data indicates a 20% drop in average blood glucose levels over six months.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
